natalizumab (tysabri) Report issue

Biologics mAb Approved FDA Accelerated Approval FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$1039.4292

VA Big4

$4138.5900

VA FSS

$5773.6800

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
natalizumab 300 mg / 15 mL (15 mL INJECTION) $1039.4292 AUS PBS generic
  • Tysabri (1)
    		•  Biogen Australia Pty Ltd
    natalizumab 300 mg / 15 mL (15 mL INJECTION) $4138.5900 VA Big4
  • TYSABRI (1)
    		•  Biogen U.S. Corporation
    natalizumab 300 mg / 15 mL (15 mL INJECTION) $5773.6800 VA FSS
  • TYSABRI (1)
    		•  Biogen U.S. Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue